Hepatitis C in Pakistan: Why the Rate Is Among the World’s Highest

Pakistan has a hepatitis problem that most people here have never been told the size of. Hepatitis C in Pakistan sits at or near the top of the global table, a slow blood-borne virus that can destroy the liver over decades while causing almost no symptoms. The World Health Organization has repeatedly flagged Pakistan as one of the largest reservoirs of this infection in the world. Local programmes and surveys put the number of people living with the virus in the millions, with adult prevalence often quoted around 5 to 6 percent. That is not a rounding error. It is one in every seventeen or so adults walking around with a virus many of them do not know they carry.

This article explains why hepatitis C in Pakistan reached this level, how the virus actually works inside the body, and the genuinely good news: this is now a curable disease, and the cure is cheaper here than almost anywhere on earth.

How big is the problem, really

Pakistan’s hepatitis C numbers are large enough that global health bodies treat the country as a special case. The WHO has named Pakistan among the highest-burden nations for the virus, and modelling work has suggested that without action the country could account for a sizeable share of the world’s new infections each year. You can read the WHO’s framing of the global threat in its hepatitis C fact sheet.

The figure most often repeated, around 10 million people infected, comes from national survey work and programme estimates. The 2017 to 2018 National Hepatitis Survey and earlier demographic studies put adult anti-HCV prevalence in the range of roughly 5 to 6 percent in many districts, with some pockets far higher. Compare that to a global average that sits below 1 percent and you start to see why hepatitis C in Pakistan stands out as a national emergency rather than a niche disease.

Why these numbers are probably an undercount

Most carriers have no idea they are infected, because the virus rarely makes you feel ill in its early years. Many of the surveys rely on the antibody test, which tells you a person was exposed at some point but does not separate cleared infections from active ones. The real story is messier than a single percentage, but every serious estimate lands in the same place: Pakistan has a very high prevalence, and a large untested population sitting underneath the official count.

How hepatitis C in Pakistan actually works in the body

Hepatitis C is a virus that targets the liver. Once it enters the bloodstream, it travels to liver cells and uses them as a factory to copy itself. The immune system fights back, and in roughly one in four people it wins, clearing the virus within six months. For the rest, the infection becomes chronic and settles in for the long haul.

Here is the part that makes it dangerous. The fight between the virus and your immune system causes steady, low-grade inflammation in the liver. Year after year, that inflammation lays down scar tissue. A little scarring is fibrosis. Heavy, widespread scarring is cirrhosis, where the liver becomes stiff and stops doing its job. On top of cirrhosis, the risk of liver cancer (hepatocellular carcinoma) climbs sharply. Cleveland Clinic has a clear plain-language walkthrough of this progression in its hepatitis C overview.

Why it stays silent so long

The liver is a forgiving organ. It can lose a large chunk of its working capacity before symptoms appear, so a person can carry an active infection for ten or twenty years and feel completely normal. When symptoms finally come, they are vague at first: tiredness, poor appetite, aching joints. The dramatic signs (yellow eyes, swollen belly, confusion) tend to arrive only once cirrhosis is advanced. This long silence is exactly why testing matters so much, and why so many Pakistani patients are diagnosed late. If you want a broader picture of how the body manages chronic infection and repair, our explainer on why we get sick and how the body heals covers the immune mechanics in plain terms.

Why Pakistan’s rate climbed so high

A virus this common does not spread by accident. It rides on specific, repeatable habits in the health and grooming systems people use every day. Almost every major driver of hepatitis C in Pakistan comes back to one theme: blood from one person reaching the bloodstream of another, usually through equipment that should have been single-use or properly sterilised.

Reused syringes and unsafe injections

Pakistan has one of the highest per-capita rates of therapeutic injection use in the world. Patients often expect an injection for minor complaints, and some providers oblige with jabs that a tablet would have handled. When a syringe or needle is reused between patients, even once, it becomes a direct highway for the virus. Research published through PubMed Central has repeatedly tied unsafe injection practices to a large share of new hepatitis C infections in the country. This single factor is widely considered the biggest contributor to the epidemic.

Unscreened or poorly screened blood

Blood transfusions save lives, but only when the blood is screened for viruses first. In settings where screening is incomplete or skipped, a transfusion can pass hepatitis C straight into a patient. Thalassaemia patients, who need repeated transfusions, have historically faced a high risk in places where the blood supply was not reliably tested. National efforts have improved screening over the years, but the legacy of past gaps is part of why prevalence is so high today.

Barbers, dentists, and piercing

The danger reaches well beyond hospitals. A shared straight razor at the barber, a dental drill or extraction tool that was not properly sterilised, an ear or nose piercing done with a reused needle: each can carry trace blood from a previous customer. Reused glucose-check lancets, the small spring-loaded pricking devices used to test blood sugar, are another quiet route, especially when one device is shared across several people. None of these feel risky in the moment, which is what makes them so effective at moving the virus around.

The habit loop behind the spread

Notice the pattern. Most of these routes are not dramatic crimes. They are small, routine shortcuts repeated millions of times: one extra injection, one razor that gets a quick wipe instead of a fresh blade, one lancet used twice to save a rupee. Multiply that across a population of over 240 million and you get an epidemic. The good news is that the same logic works in reverse. Change the small habits and the chain breaks.

The hopeful part: hepatitis C is now curable

For most of medical history, hepatitis C treatment was brutal. The old regimens used interferon injections plus ribavirin, ran for up to a year, made people feel terrible, and cured only about half of patients. That era is over.

Since the mid-2010s, a class of medicines called direct-acting antivirals, or DAAs, has changed everything. These are tablets taken once a day for 8 to 12 weeks. They attack the virus directly at the points it needs to copy itself, and they cure more than 95 percent of patients across most genotypes. Side effects are usually mild. The WHO now frames hepatitis C as an eliminable disease precisely because of these drugs.

We went from a year of miserable injections that helped half of patients to twelve weeks of tablets that cure almost everyone. Few diseases have flipped this completely.

Why the cure is so affordable in Pakistan

When DAAs first launched in the United States, a course could cost tens of thousands of dollars. In Pakistan, the story is very different. Local pharmaceutical companies produce generic versions of sofosbuvir and daclatasvir, and a full curative course can cost a small fraction of the Western price, sometimes in the range of a few thousand rupees through public programmes or low-cost generics. Pakistan’s pharmaceutical manufacturing capacity, which usually gets talked about as a trade story, turns out to be a public-health asset here. Affordable generics are part of what makes national-scale treatment even thinkable. For a sense of how access to medicine and resistance trends shape Pakistani public health more broadly, see our piece on antibiotic resistance in Pakistan.

Treatment is not a vaccine

One honest caveat. Curing hepatitis C with DAAs does not make you immune. There is no vaccine for hepatitis C, unlike hepatitis A and B. A person who is cured can be reinfected if they are exposed again through the same routes. That is why prevention habits still matter even after a successful cure.

Getting tested: the simple step that changes everything

You cannot treat what you have not found, and you cannot find hepatitis C by how you feel. The entry point is a cheap, widely available blood test.

The first test is the anti-HCV antibody test. It checks whether your body has ever made antibodies against the virus, which means you were exposed at some point. A positive antibody result does not by itself mean you have an active infection, because some people cleared the virus naturally. To confirm active infection, doctors order an HCV RNA (PCR) test, which detects the virus itself. If that is positive, you have an ongoing infection that can be treated.

Step	What it is	What the result tells you
1. Anti-HCV antibody test	A simple blood test, often available as a rapid test	Whether you have ever been exposed to the virus
2. HCV RNA (PCR) test	A blood test that looks for the virus itself	Whether you have an active, current infection
3. Genotype + liver assessment	Blood test plus scan or fibrosis check	Which virus strain you have and how much liver damage exists
4. DAA treatment	Daily tablets for 8 to 12 weeks	Clears the virus in more than 95 percent of patients
5. SVR test (12 weeks after)	Repeat PCR test	Confirms you are cured if the virus is undetectable

Who should get tested in Pakistan

Given how common the virus is here, a broad approach makes sense. Anyone who has had a transfusion, surgery, dialysis, or many injections over the years should be screened. So should household members of someone who is infected, people who share grooming items, and anyone with unexplained liver enzyme elevations on a routine blood test. Pregnant women are increasingly screened too, since the virus can occasionally pass to the baby. If your blood report ever comes back with raised liver markers, ask specifically about a hepatitis screen. Our explainer on why blood is red and what blood tests reveal is a useful companion if you want to understand what those liver numbers actually mean.

Prevention: breaking the chain

Because the routes are so specific, prevention is unusually practical. You do not need fancy equipment. You need a few firm habits and the confidence to insist on them.

1. Insist on a single-use, sealed syringe for any injection. Watch it being opened from the packet. Refuse a jab if you cannot see this.
2. Question whether you need the injection at all. Many conditions are treated just as well with tablets. Ask your doctor.
3. Demand a fresh razor blade at the barber. A new disposable blade for every customer is the only safe option. The same goes for piercing needles.
4. Never share personal items that can carry blood: razors, toothbrushes, nail clippers, and glucose lancets.
5. Use only screened blood for transfusions, from a reputable blood bank that tests every unit.
6. Choose clean dental and beauty settings where you can see instruments being sterilised or replaced.

Small costs, large protection

The interesting thing about this list is how cheap it is. A fresh razor blade costs a few rupees. A new lancet costs almost nothing. The price of prevention is tiny next to the cost of a scarred liver and a lifetime of complications. In a country where the virus is this common, treating every needle and blade as a possible carrier is simply rational caution, not paranoia.

The national elimination goal

The WHO has set a global target to eliminate viral hepatitis as a public-health threat by 2030, meaning a large cut in new infections and deaths. For Pakistan, that is an enormous undertaking given the starting numbers, but it is no longer a fantasy because the cure exists and is affordable. Pakistan has launched large-scale programmes, including provincial and federal hepatitis initiatives and the prime-minister-level elimination push, aimed at mass screening and free or subsidised DAA treatment. Specialist institutions like the Pakistan Kidney and Liver Institute (PKLI) and academic centres such as Aga Khan University have been central to research and care.

The maths of elimination is straightforward even if the logistics are not. Find people through testing, cure them with tablets, and stop new infections by fixing injection and blood-safety practices. Do all three at scale and the virus has nowhere to go.

Common belief	What is actually true
“Hepatitis C is a death sentence.”	It is curable in most cases with 8 to 12 weeks of tablets.
“If I felt fine, I cannot have it.”	The virus is usually silent for years; you can feel fine and still be infected.
“There is a vaccine I can get.”	There is no hepatitis C vaccine; prevention relies on safe needles, blood, and grooming.
“Sharing food spreads it.”	It does not spread through food, water, or casual contact. It needs blood-to-blood exposure.
“Treatment is unaffordable here.”	Pakistani generic DAAs are among the cheapest in the world.

What individuals can do while the system catches up

Government programmes will not reach everyone overnight. In the meantime, the most powerful move any reader can make is personal: get the one-time test, encourage family members to do the same, and adopt the prevention habits above. If everyone who has ever had an injection or a barber shave got screened once, the hidden half of this epidemic would come into view, and a large number of curable infections would be caught before they become cirrhosis.

Frequently asked questions

Is hepatitis C curable in Pakistan?

Yes. Direct-acting antiviral tablets cure more than 95 percent of patients in 8 to 12 weeks, and Pakistan produces affordable generic versions through local manufacturers. Public hepatitis programmes also offer free or subsidised treatment in many areas. The main barrier is not the cure but diagnosis, since most infected people have never been tested and do not know they carry the virus.

How does hepatitis C spread in Pakistan?

The virus is blood-borne. The leading routes here are reused syringes and needles, unnecessary therapeutic injections, poorly screened blood transfusions, and shared or unsterilised equipment at barbers, dentists, and piercing stalls. Reused glucose-check lancets are another quiet source. It does not spread through food, water, hugging, or casual everyday contact between people.

What are the symptoms of hepatitis C?

For years, usually none. The virus is famously silent, which is why so many people are diagnosed late. When symptoms do appear they are often vague, such as fatigue, poor appetite, or aching joints. Clear signs like yellow eyes, dark urine, or a swollen abdomen tend to show up only once cirrhosis is advanced, so testing matters more than waiting for symptoms.

Who should get tested for hepatitis C?

Anyone who has ever had a blood transfusion, surgery, dialysis, frequent injections, a dental procedure, a barber shave with a shared razor, or a piercing or tattoo should get a one-time test. Household members of an infected person and anyone with raised liver enzymes on routine blood work should also be screened. Given the high local prevalence, broad testing is sensible.

Is there a vaccine for hepatitis C?

No. There are vaccines for hepatitis A and hepatitis B, but not for hepatitis C, because the virus mutates rapidly. Prevention therefore relies entirely on avoiding blood-to-blood exposure: single-use needles, screened blood, fresh razor blades, and not sharing personal grooming items. Being cured of the virus does not make you immune, so you can be reinfected if exposed again.

How much does hepatitis C treatment cost in Pakistan?

Far less than in Western countries. While a DAA course can run into tens of thousands of dollars abroad, Pakistani generic versions of medicines like sofosbuvir and daclatasvir cost a small fraction of that, sometimes only a few thousand rupees, and government programmes provide free or heavily subsidised treatment in many districts. Affordable local manufacturing is a major reason national-scale treatment is feasible.

Can hepatitis C come back after treatment?

The cure itself is durable. Once the virus is cleared and a follow-up test 12 weeks later confirms it is undetectable, that infection is gone for good. However, treatment does not provide immunity. A cured person can catch hepatitis C again if exposed to infected blood through an unsafe injection, a shared razor, or unscreened blood, so prevention habits still apply after the cure.